This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Other lack of coordination
R18_OTHER_LACK_COORD
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
630 |
4. Check minimum number of eventsNone |
630 |
5. Include endpointsNone |
630 |
6. Filter based on genotype QC (FinnGen only) |
614 |
Control definitions (FinnGen only)
- Control exclude
- R18_SYMPTOMS_SIGNS_INVOLVI_NERVOUS_MUSCULOS_SYSTEMS
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- R2[5-9]
- Name in latin
- Alia absentia coordinationis musculorum
Similar endpoints
↥List of similar endpoints to
Other lack of coordination
based on the number of shared cases.
Similar with more cases:
- Symptoms and signs involving the nervous and musculoskeletal systems
- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 614 | 303 | 311 |
| Unadjusted period prevalence (%) | 0.13 | 0.11 | 0.14 |
| Median age at first event (years) | 59.77 | 55.88 | 63.55 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 630
- Matched controls
- 6300
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R27.0
ICD-10 Finland
Ataxia, unspecified
8557.9
307.7
531
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
80.4
219.4
118
18
R27.8
ICD-10 Finland
Other and unspecified lack of coordination
+∞
111.9
104
*
TAB00
NOMESCO Finland
Lumbar puncture
11.7
105.3
118
122
R25.1
ICD-10 Finland
Tremor, unspecified
20.8
82.4
64
34
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
6.8
79.7
145
265
N99
ICPC
Neurological disease other
26.7
67.3
47
19
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
6.1
65.1
129
254
N03AE01
ATC
clonazepam; systemic
7.9
63.2
94
137
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
118.5
60.1
64
6
G11.9
ICD-10 Finland
Hereditary ataxia, unspecified
611.1
57.6
56
*
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
8.8
56.5
75
95
AA1AD
NOMESCO Finland
CT of head and brain
3.6
53.4
274
1106
N29
ICPC
Neurological sympt/complt other
13.0
46.7
46
38
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
6.8
46.2
77
126
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
6.0
44.8
86
162
N28
ICPC
Limited function/disability (N)
14.3
42.0
39
29
XA800
NOMESCO Finland
Neuropsychological investigation
6.8
41.6
69
112
R42
ICD-10 Finland
Dizziness and giddiness
3.3
40.5
216
868
R26.0
ICD-10 Finland
Ataxic gait
+∞
37.9
36
*
L28
ICPC
Limited function/disability (L)
3.4
37.9
173
630
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
7.3
35.3
54
80
G11.2
ICD-10 Finland
Late-onset cerebellar ataxia
+∞
32.6
31
*
A28
ICPC
Limited function/disability NOS
3.1
32.4
168
654
M03BX01
ATC
baclofen; systemic
9.5
30.6
37
41
R1250
NOMESCO Finland
Evaluation of functional capability
8.0
30.0
42
56
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.2
29.4
86
229
N03AX12
ATC
[U] gabapentin; oral
3.1
29.3
155
607
R53
ICD-10 Finland
Malaise and fatigue
2.6
26.4
202
956
R4120
NOMESCO Finland
Occupational therapy
4.2
25.6
74
195
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
6.7
25.1
41
65
SPAT1229
SPAT
Assessment of need for aid
3.8
24.6
83
244
R20.2
ICD-10 Finland
Paraesthesia of skin
4.4
24.4
66
165
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.7
24.3
86
261
G11.8
ICD-10 Finland
Other hereditary ataxias
+∞
24.1
23
*
R56.8
ICD-10 Finland
Other and unspecified convulsions
4.7
23.4
57
131
G35
ICD-10 Finland
Multiple sclerosis
9.7
22.8
27
29
N06AX21
ATC
duloxetine; oral
3.2
22.6
100
349
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
8.4
21.9
29
36
G31.9
ICD-10 Finland
Degenerative disease of nervous system, unspecified
45.1
21.6
26
6
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.3
21.5
239
1319
G25.0
ICD-10 Finland
Essential tremor
6.4
21.3
36
59
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
7.0
20.6
32
48
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
4.6
20.5
50
115
G31.2
ICD-10 Finland
Degeneration of nervous system due to alcohol
19.6
20.1
30
16
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
4.2
19.8
55
140
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.5
19.5
149
693
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.6
19.0
131
579
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
3.6
18.9
66
198
R5110, ,
SPAT
3.7
18.7
63
184
SPAT1216
SPAT
Assessment of functional ability
2.6
18.7
129
570
N03AX14
ATC
levetiracetam; systemic
5.9
18.2
33
58
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.8
18.0
98
383
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.8
17.6
97
382
N06AB04
ATC
citalopram; systemic
2.4
17.6
151
737
H55
ICD-10 Finland
Nystagmus and other irregular eye movements
24.9
17.4
24
10
N03AX09
ATC
lamotrigine; oral
4.4
17.3
45
109
R4130
NOMESCO Finland
Speech therapy
5.5
17.2
34
65
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
3.1
16.9
75
261
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
6.7
16.8
27
42
Z2445
NOMESCO Finland
Psychologist
4.1
16.8
48
125
R4110
NOMESCO Finland
Physiotherapy
2.1
16.7
208
1179
Z3226
NOMESCO Finland
Physiotherapist
2.3
16.7
147
723
A04
ICPC
Weakness/tiredness general
2.5
16.1
117
527
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
14.0
16.1
27
20
G40.9
ICD-10 Finland
Epilepsy, unspecified
4.9
15.8
35
74
F10.25
ICD-10 Finland
Alcohol dependence continuous use
7.1
15.8
24
35
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.8
15.5
83
321
N03AG01
ATC
valproic acid; systemic, rectal
3.6
15.0
52
155
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.5
15.0
53
160
N17
ICPC
Vertigo/dizziness
2.6
14.8
92
384
SPAT1215
SPAT
Assessment of need for medical rehabilitation
4.2
14.7
40
100
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
13.0
14.5
25
20
SPAT1231
SPAT
Assessment of adjustments needed in living environment
5.7
14.4
27
49
N03AF02
ATC
oxcarbazepine; oral
4.8
14.4
33
72
N03AX16
ATC
[U] pregabalin
2.1
14.3
164
893
N02BF01
ATC
gabapentin; oral
3.1
14.3
64
224
N18
ICPC
Paralysis/weakness
5.9
14.2
26
46
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
3.4
14.2
54
171
R26.2
ICD-10 Finland
Difficulty in walking, not elsewhere classified
43.6
14.2
17
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.4
14.2
106
483
N06AA09
ATC
amitriptyline; systemic
2.8
14.2
75
288
R47.1
ICD-10 Finland
Dysarthria and anarthria
11.2
14.1
26
24
SPAT1234
SPAT
Support of social functional capacity
3.6
14.0
47
137
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
11.8
13.9
25
22
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.7
13.9
78
309
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.8
13.7
42
115
XF400
NOMESCO Finland
ECG with 12 standard connections
2.3
13.7
127
635
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
3.1
13.6
58
197
Z31.5
ICD-10 Finland
Genetic counselling
3.5
13.6
49
150
M48.0
ICD-10 Finland
Spinal stenosis
2.4
13.1
98
445
R51.80
ICD-10 Finland
Headache
2.3
13.1
111
533
M54.1
ICD-10 Finland
Radiculopathy
4.0
13.0
37
96
N03AF01
ATC
carbamazepine; oral, rectal
3.4
12.8
47
145
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.3
12.6
110
534
Z2446
NOMESCO Finland
Social worker
2.8
12.6
66
252
7812A
ICD-9 Finland
Symptoms involving nervous and musculoskeletal systems, Abnormality of gait
+∞
12.5
12
*
C07AA05
ATC
propranolol; systemic
2.1
12.4
138
740
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.9
12.3
61
226
N03AX11
ATC
topiramate; oral
5.1
12.3
26
53
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
4.6
12.0
29
66
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.4
12.0
45
141
H53.2
ICD-10 Finland
Diplopia
4.0
12.0
34
88
EBA15
NOMESCO Finland
Extraction of multiple teeth
3.8
11.8
37
103
R55
ICD-10 Finland
Syncope and collapse
2.4
11.7
86
387
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.9
11.7
35
94
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
23.4
11.6
16
7
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.9
11.4
189
1161
SPAT1254
SPAT
Administration of medicine
2.2
11.3
106
530
U07
ICPC
Urine symptom/complaint other
2.8
11.3
58
219
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.6
11.2
68
280
G72.9
ICD-10 Finland
Myopathy, unspecified
14.2
11.0
18
13
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.7
11.0
63
252
A01
ICPC
Pain general/multiple sites
2.5
10.9
69
290
Z01.8
ICD-10 Finland
Other specified special examinations
2.0
10.8
153
889
N05AH04
ATC
quetiapine; oral
2.1
10.8
118
626
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
4.4
10.7
27
64
R25.2
ICD-10 Finland
Cramp and spasm
8.7
10.6
22
26
N06AX11
ATC
mirtazapine; oral
1.8
10.5
215
1404
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
5.5
10.5
20
37
R25.8
ICD-10 Finland
Other and unspecified abnormal involuntary movements
+∞
10.4
10
*
R27
ICD-10 Finland
Other lack of coordination
+∞
10.4
10
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
10.4
189
1190
N05BA01
ATC
diazepam; systemic, rectal
2.2
10.4
93
456
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
19.2
10.3
15
8
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
5.4
10.2
20
38
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.2
10.1
94
468
G25.2
ICD-10 Finland
Other specified forms of tremor
14.9
10.0
16
11
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.4
9.9
74
335
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
4.8
9.8
22
47
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
4.2
9.8
26
64
L99
ICPC
Musculoskeletal disease other
5.4
9.7
19
36
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
5.4
9.7
19
36
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.1
9.6
99
513
R4110, ,
SPAT
2.5
9.4
63
271
XKC03
NOMESCO Finland
Water cystometry
3.9
9.4
28
75
G20
ICD-10 Finland
Parkinson disease
4.1
9.4
26
66
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.3
9.4
77
363
S06.0
ICD-10 Finland
Concussion
2.2
9.4
80
384
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
8.9
9.3
19
22
WX892
NOMESCO Finland
Monitored bed care
2.5
9.3
61
260
R13
ICD-10 Finland
Dysphagia
2.7
9.3
53
211
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
7.5
9.3
21
29
R11
ICD-10 Finland
Nausea and vomiting
2.4
9.2
64
281
G24.9
ICD-10 Finland
Dystonia, unspecified
37.3
9.0
11
*
NXL00
NOMESCO Finland
Biopsy of muscle
18.9
9.0
13
7
R02
ICPC
Shortness of breath/dyspnoea
2.1
8.9
85
427
R47.8
ICD-10 Finland
Other and unspecified speech disturbances
8.8
8.8
18
21
G62.8
ICD-10 Finland
Other specified polyneuropathies
9.7
8.8
17
18
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.6
8.8
52
211
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
4.0
8.8
25
65
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.0
8.7
103
560
N06AB10
ATC
escitalopram; oral
1.9
8.6
122
705
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
8.4
8.6
18
22
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
2.9
8.6
40
143
N02BE01
ATC
paracetamol; systemic, rectal
2.1
8.6
548
4820
K92.0
ICD-10 Finland
Haematemesis
4.3
8.5
22
53
AA5EN
NOMESCO Finland
Brain reseptor or transprot protein distribution isotope imaging
27.9
8.5
11
*
ZX120
NOMESCO Finland
Intravenous
2.2
8.4
72
346
F44.4
ICD-10 Finland
Dissociative motor disorders
+∞
8.3
8
*
G71.3
ICD-10 Finland
Mitochondrial myopathy, not elsewhere classified
+∞
8.3
8
*
SPAT1301
SPAT
No procedures
1.7
8.3
196
1317
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
2.5
8.3
55
236
A99
ICPC
Disease/condition unspecnature/site
2.3
8.2
65
302
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.0
8.2
98
535
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
8.2
292
2184
Z50.1
ICD-10 Finland
Other physical therapy
2.7
8.1
43
165
TKC22
NOMESCO Finland
Catheterisation instruction
3.9
8.0
23
60
W19
ICD-10 Finland
Unspecified fall
2.2
8.0
69
332
UKC02
NOMESCO Finland
Cystoscopy
1.9
7.9
110
632
XCK00
NOMESCO Finland
Perimetry
2.5
7.9
48
198
N04BC05
ATC
pramipexole; oral
2.4
7.8
54
236
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
3.7
7.8
24
66
N19
ICPC
Speech disorder
6.0
7.7
20
34
Z50.5
ICD-10 Finland
Speech therapy
4.6
7.7
18
40
R33
ICD-10 Finland
Retention of urine
2.2
7.7
63
297
SPAT1245
SPAT
Provision of support and information to patient’s family members
2.8
7.7
37
135
109
Kela drug reimbursment
Multiple sclerosis
8.2
7.6
16
20
A06AD11
ATC
lactulose; oral
1.9
7.5
95
527
S01EC01
ATC
acetazolamide; systemic
3.8
7.5
23
63
G44.2
ICD-10 Finland
Tension-type headache
2.0
7.4
83
441
N05CD07
ATC
temazepam; oral
2.0
7.4
82
434
N05BA04
ATC
oxazepam; oral
1.7
7.4
159
1037
R60.0
ICD-10 Finland
Localized oedema
2.1
7.4
78
406
F10.09
ICD-10 Finland
Alcohol intoxication UNS
4.1
7.4
20
50
N30.0
ICD-10 Finland
Acute cystitis
1.9
7.4
92
509
F80.1
ICD-10 Finland
Expressive language disorder
8.5
7.4
15
18
H53.1
ICD-10 Finland
Subjective visual disturbances
2.5
7.3
45
186
G11.18
ICD-10 Finland
Early-onset cerebellar ataxia
+∞
7.3
7
*
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.2
7.3
61
290
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
4.4
7.3
18
42
M54.5
ICD-10 Finland
Low back pain
1.6
7.2
208
1463
F05.9
ICD-10 Finland
Delirium, unspecified
4.6
7.2
17
38
R60.9
ICD-10 Finland
Oedema, unspecified
2.7
7.2
39
152
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
20.3
7.1
10
5
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
20.3
7.1
10
5
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
7.1
140
891
XKD06
NOMESCO Finland
Physiologic investigation of micturition
3.2
7.1
28
91
ZXE10
NOMESCO Finland
More than one and less than three hours
1.6
7.1
223
1603
G81.9
ICD-10 Finland
Hemiplegia, unspecified
8.9
7.1
14
16
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
2.2
7.1
61
294
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.4
7.0
50
222
J01DB01
ATC
cefalexin; oral
1.7
7.0
501
4363
R1260
NOMESCO Finland
Evaluation of communicative skills
4.1
6.9
19
48
N06AX03
ATC
mianserin; oral
2.7
6.9
36
137
U04
ICPC
Incontinence urine
2.6
6.9
41
167
ZY010
NOMESCO Finland
Hospital outpatient
2.6
6.9
38
149
R41.0
ICD-10 Finland
Disorientation, unspecified
3.3
6.9
25
77
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.9
6.9
31
109
N05AN01
ATC
lithium; oral
3.9
6.9
20
53
V700A
ICD-9 Finland
General medical examination, Routine general medical examination at a health care facility
3.9
6.9
20
53
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
6.8
165
1108
N04AA02
ATC
biperiden; systemic
4.3
6.8
17
40
G04.9
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis, unspecified
40.5
6.8
8
*
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
4.0
6.8
19
49
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
3.0
6.7
30
105
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
4.1
6.7
18
45
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.5
6.7
40
164
N05AH03
ATC
olanzapine; systemic
2.6
6.6
39
158
L03.9
ICD-10 Finland
Cellulitis, unspecified
4.2
6.6
17
41
OAB43, ,
SPAT
0.4
6.6
42
886
Z3231
NOMESCO Finland
Registered nurse
1.6
6.5
170
1162
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.6
6.5
37
148
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.8
6.4
103
616
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.6
6.4
162
1098
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
7.5
6.4
14
19
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.9
6.4
79
434
N02AA05
ATC
oxycodone; systemic
1.8
6.4
113
696
F99
ICD-10 Finland
Mental disorder, not otherwise specified
4.1
6.4
17
42
N05CF01
ATC
zopiclone; oral
1.6
6.4
192
1360
N87
ICPC
Parkinsonism
6.1
6.3
16
27
H81.4
ICD-10 Finland
Vertigo of central origin
11.2
6.3
11
10
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.9
6.3
83
467
K05.30
ICD-10 Finland
Periodontitis complex
1.9
6.3
85
483
N02AX02
ATC
tramadol; systemic, rectal
1.5
6.2
256
1945
G24.3
ICD-10 Finland
Spasmodic torticollis
7.8
6.1
13
17
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
2.8
6.1
29
105
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.0
6.1
69
368
I95.1
ICD-10 Finland
Orthostatic hypotension
3.0
6.1
27
94
G62.1
ICD-10 Finland
Alcoholic polyneuropathy
12.7
6.1
10
8
G31.8
ICD-10 Finland
Other specified degenerative diseases of nervous system
12.7
6.1
10
8
G91.1
ICD-10 Finland
Obstructive hydrocephalus
12.7
6.1
10
8
183
Kela drug reimbursment
Lamotrigin and topiramate
8.7
6.1
12
14
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
8.7
6.1
12
14
J01MA02
ATC
ciprofloxacin; systemic
1.5
6.1
231
1722
M79.6
ICD-10 Finland
Pain in limb
1.5
6.0
239
1796
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
82
90
10.32
69.30
1.4
1.4
3.61
3.69
mmol/l
0.26
76
84
338
1489
3.74
58.69
2.5
2.1
217.39
260.16
u/l
0.29
325
1399
73
88
9.25
57.25
1.4
1.4
6.93
14.35
e6/l
0.39
59
69
73
88
9.25
57.25
1.4
1.5
1119.56
1393.73
e6/l
0.07
61
71
47
29
17.43
56.09
1.1
1.0
—
—
—
0
0
47
39
12.94
47.55
1.1
1.1
—
—
—
0
0
47
50
10.08
40.24
1.1
1.1
—
—
—
0
0
46
48
10.26
39.92
1.1
1.1
—
—
—
0
0
34
25
14.32
36.77
1.1
1.1
1.00
1.01
u/l
0.08
18
14
355
2057
2.66
31.73
2.2
2.0
91.82
93.80
pmol/l
0.37
204
1067
385
2525
2.35
23.51
6.6
7.4
1.22
1.22
mmol/l
0.65
350
2149
137
567
2.81
22.94
1.8
1.8
1.76
1.51
%
1.93
120
488
109
398
3.10
22.88
1.8
3.5
67.05
66.38
g/l
0.37
100
361
358
2320
2.26
21.89
5.9
6.8
1.22
1.21
mmol/l
0.35
337
2104
184
940
2.35
19.52
1.9
1.7
1096.37
1199.10
nmol/l
0.76
151
702
416
2991
2.15
18.02
5.4
5.1
6.58
6.70
mmol/l
0.52
399
2804
24
9
27.64
17.93
1.2
1.1
16.34
17.65
umol/l
—
24
9
26
41
6.57
15.94
1.3
1.3
—
—
—
0
0
209
1218
2.07
15.40
1.5
1.5
22.08
20.63
nmol/l
0.25
188
1012
53
166
3.39
14.16
1.6
2.9
2.67
3.01
g/l
1.91
47
149
150
801
2.15
13.72
4.1
4.4
0.81
0.81
mmol/l
0.12
139
752
151
810
2.14
13.64
1.9
2.6
28.93
29.86
s
1.87
146
780
314
2178
1.88
13.43
6.3
5.0
35.60
35.35
g/l
0.34
300
2034
54
178
3.22
13.29
1.7
2.8
3.45
3.61
g/l
0.51
48
162
21
14
15.47
13.17
1.1
1.4
234.93
81.28
nmol/l
—
14
9
54
179
3.21
13.17
1.7
2.8
6.99
7.32
g/l
0.80
48
162
54
179
3.21
13.17
1.7
2.8
—
—
—
0
0
188
1119
1.97
12.66
1.3
1.3
1.55
1.29
u/ml
0.13
45
289
23
22
10.80
12.34
1.2
1.2
—
—
—
0
0
91
411
2.42
12.32
2.3
2.8
10.00
10.53
g/l
0.60
84
375
50
165
3.21
12.28
1.7
2.9
9.38
10.46
g/l
1.01
43
147
276
1877
1.84
12.23
4.3
3.3
—
—
—
0
0
468
3768
1.94
11.79
4.5
4.1
12.33
12.11
mm/h
0.11
436
3463
333
2416
1.80
11.76
9.7
14.6
1.15
1.28
inr
1.91
76
682
44
140
3.30
11.46
1.7
3.1
0.06
0.00
g/l
0.49
39
130
482
3941
1.95
11.30
8.1
7.7
81.56
81.47
u/l
0.01
448
3692
46
154
3.14
11.04
1.8
3.1
0.36
1.27
g/l
1.51
38
138
148
849
1.97
10.89
1.8
1.8
—
—
—
0
0
250
1704
1.77
10.60
3.0
3.5
2.35
2.35
mmol/l
0.05
217
1498
353
2659
1.75
10.48
6.1
6.6
10.70
11.75
umol/l
0.80
339
2532
335
2488
1.74
10.45
6.7
6.2
27.21
27.61
%
0.27
322
2342
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
21
24
9.01
10.34
1.0
1.2
—
—
—
0
0
330
2450
1.73
10.23
6.8
6.0
56.93
57.31
%
0.22
318
2309
236
1596
1.77
10.19
3.1
2.5
52.40
60.68
u/l
1.74
221
1487
383
2974
1.73
9.99
8.6
9.4
4.19
4.13
e9/l
0.18
339
2597
39
128
3.18
9.68
1.8
3.2
0.00
0.00
g/l
-0.00
34
121
42
145
3.03
9.58
1.8
3.0
39.45
37.45
g/l
1.21
36
128
18
18
10.26
9.57
1.4
1.4
—
—
—
0
0
25
62
4.16
9.32
1.0
1.1
—
—
—
0
0
39
131
3.11
9.32
1.8
3.2
0.00
0.00
g/l
-0.00
34
122
12
5
24.41
8.93
1.4
1.2
—
—
—
0
0
170
1084
1.78
8.77
3.0
2.6
6.69
5.74
e6/l
0.35
151
974
120
687
1.92
8.73
5.3
6.5
1.04
1.06
mmol/l
0.21
115
632
27
77
3.62
8.33
1.3
1.1
125.07
40.00
iu/ml
0.30
14
19
43
163
2.76
8.31
1.2
1.1
—
—
—
0
0
43
164
2.74
8.21
1.2
1.1
—
—
—
0
0
86
447
2.07
8.20
5.2
8.0
1.37
1.34
mmol/l
0.10
80
440
185
1231
1.71
8.13
2.2
2.5
—
—
—
0
0
154
977
1.76
8.00
4.2
3.8
251.98
329.71
ng/l
0.17
122
795
64
303
2.24
7.73
1.6
1.4
—
—
—
0
0
67
325
2.19
7.63
1.6
1.6
—
—
—
0
0
447
3757
1.65
7.42
4.2
3.7
14.95
14.84
pmol/l
0.39
405
3368
101
579
1.89
7.26
1.7
1.8
—
—
—
0
0
222
1589
1.61
7.20
4.1
3.4
19.97
114.49
e6/l
1.59
182
1230
271
2036
1.58
7.15
2.6
2.3
75.85
77.40
nmol/l
0.35
246
1792
101
582
1.88
7.14
1.7
1.8
—
—
—
0
0
400
3295
1.59
7.00
4.1
3.1
51.66
51.19
u/l
0.05
380
3073
28
92
3.14
6.97
1.2
1.3
—
—
—
0
0
28
92
3.14
6.97
1.2
1.3
—
—
—
0
0
72
377
2.03
6.72
2.0
1.7
—
—
—
0
0
203
1443
1.60
6.68
3.9
3.2
0.50
0.42
e6/l
0.21
167
1087
259
1948
1.56
6.68
4.6
3.6
57.37
42.56
ng/l
0.32
202
1374
88
502
1.88
6.40
4.0
4.5
1.20
1.89
mmol/l
1.00
75
412
157
1058
1.64
6.38
1.6
1.7
435.31
16896986.43
pmol/l
1.06
134
870
16
27
6.05
6.34
1.2
1.0
237.43
237.71
ng/l
—
7
14
96
569
1.81
6.18
4.9
9.0
4.96
5.10
kpa
0.67
89
541
96
570
1.81
6.14
4.9
9.0
11.83
11.92
kpa
0.06
89
544
139
916
1.66
6.14
3.2
3.1
2.45
2.45
mmol/l
0.16
113
815
38
159
2.48
6.08
1.5
1.2
—
—
—
0
0
80
451
1.89
6.03
2.5
2.2
377.91
372.15
nmol/l
0.09
75
420
132
864
1.67
5.97
3.5
3.1
4.20
2.15
e6/l
0.98
85
489
87
506
1.83
5.95
4.0
4.5
5.82
5.76
kpa
0.27
82
493
68
366
1.96
5.88
3.1
5.5
0.54
1.62
mmol/l
2.01
53
280
15
27
5.66
5.71
1.2
1.0
30.00
31.92
ng/l
—
6
13
15
27
5.66
5.71
1.2
1.0
1120.33
567.93
ng/l
—
6
15
94
569
1.77
5.63
4.9
9.1
1.01
1.28
mmol/l
0.29
71
454
134
896
1.63
5.55
3.3
2.9
0.99
1.00
e6/l
0.02
87
514
158
1101
1.58
5.51
5.9
3.9
1.02
1.02
kg/l
0.46
30
158
26
95
2.81
5.43
1.2
1.2
—
—
—
0
0
12
19
6.42
5.10
1.8
2.1
2.38
1.86
umol/l
1.13
12
19
12
19
6.42
5.10
1.1
1.1
—
—
—
0
0
12
19
6.42
5.10
1.1
1.2
—
—
—
0
0
33
141
2.41
5.08
1.4
1.9
—
—
—
0
0
75
439
1.80
5.02
3.7
3.9
4.14
4.66
kpa
1.94
70
426
180
1317
1.51
4.98
2.5
2.2
3.01
3.08
mg/l
0.16
164
1108
114
753
1.63
4.93
2.1
2.4
2.30
2.33
g/l
0.14
104
704
15
33
4.63
4.89
1.2
1.2
—
—
—
0
0
10
13
7.80
4.86
1.0
1.4
—
—
—
0
0
121
814
1.60
4.85
2.1
2.5
12.33
13.07
umol/l
0.48
112
764
13
25
5.29
4.79
1.2
1.0
—
—
—
0
0
217
1661
1.47
4.77
3.3
3.5
31.54
34.10
u/l
0.47
203
1583
12
21
5.80
4.77
1.1
1.3
—
—
—
0
0
83
509
1.73
4.74
2.2
2.5
0.21
0.21
g/l
0.16
77
473
565
5229
1.78
4.70
24.3
16.8
139.35
139.67
mmol/l
1.75
556
5080
566
5243
1.78
4.66
24.5
17.0
3.98
3.98
mmol/l
0.07
557
5088
33
148
2.30
4.58
3.3
3.4
3.78
3.95
mmol/l
1.38
33
143
67
395
1.78
4.39
3.1
4.1
73.39
80.13
ng/l
0.31
60
352
34
158
2.22
4.36
1.5
1.4
0.10
0.04
iu/ml
—
7
36
10
16
6.33
4.30
1.1
1.1
—
—
—
0
0
11
20
5.58
4.30
1.1
1.2
—
—
—
0
0
11
20
5.58
4.30
1.1
1.3
—
—
—
0
0
8
9
8.98
4.29
1.1
1.0
—
—
—
0
0
8
9
8.98
4.29
1.1
1.0
—
—
—
0
0
7
6
11.78
4.28
1.1
1.0
—
—
—
0
0
11
21
5.31
4.16
3.2
2.4
45763.64
37780.95
ug/l
0.37
11
21
47
252
1.93
4.15
1.2
1.3
—
—
—
0
0
549
5076
1.63
4.14
21.6
14.5
24.99
24.62
mg/l
0.09
477
4017
22
86
2.61
4.09
1.5
1.3
—
—
—
0
0
8
10
8.09
4.07
1.1
1.2
—
—
—
0
0
506
4603
1.50
4.01
5.5
4.5
1.90
2.20
mu/l
0.58
478
4154
34
164
2.13
3.99
1.6
1.4
1.21
1.19
g/l
0.17
34
157
20
77
2.65
3.84
2.0
1.5
—
—
—
0
0
12
28
4.35
3.83
1.0
1.0
—
—
—
0
0
6
5
12.10
3.77
1.2
1.0
—
—
—
0
0
6
5
12.10
3.77
2.5
1.2
—
—
—
0
0
32
155
2.12
3.73
1.6
1.4
254.65
288.42
ug/g
0.38
20
89
32
155
2.12
3.73
1.7
1.4
0.21
0.23
g/l
0.78
32
150
13
34
3.88
3.71
1.3
2.4
—
—
—
0
0
10
20
5.06
3.70
1.0
1.1
—
—
—
0
0
41
224
1.89
3.46
2.3
1.9
—
—
—
0
0
67
424
1.65
3.43
2.7
2.3
6.67
7.35
ug/l
0.08
60
372
279
2344
1.34
3.25
2.4
2.7
—
—
—
0
0
101
714
1.49
3.21
2.3
2.4
22.44
23.34
%
0.26
91
616
260
2166
1.34
3.19
2.8
2.7
151.40
137.72
ug/l
0.26
244
1982
16
61
2.67
3.15
1.2
1.1
—
—
—
0
0
6
8
7.56
3.06
2.3
2.1
19.98
16.66
umol/l
—
6
8
13
46
2.86
2.93
1.0
1.1
—
—
—
0
0
32
171
1.92
2.91
1.5
1.7
—
—
—
0
0
16
64
2.54
2.89
1.3
1.9
—
—
—
0
0
144
1119
1.37
2.72
2.0
1.8
0.75
1.16
mg/l
3.38
106
859
86
611
1.47
2.68
10.2
6.5
—
—
—
0
0
22
410
0.52
2.43
1.3
1.7
—
—
—
0
0
30
168
1.83
2.41
4.1
3.0
—
—
—
0
0
6
12
5.04
2.40
1.2
1.1
—
—
—
0
0
26
139
1.91
2.40
2.5
2.3
49.25
112.13
ug/min
1.16
16
82
5
8
6.29
2.37
1.0
1.1
—
—
—
0
0
192
1593
1.30
2.28
4.5
3.1
6.72
7.61
mmol/l
2.53
163
1327
109
834
1.37
2.26
1.3
1.3
24.61
39.25
iu/ml
0.92
26
256
24
128
1.91
2.24
1.3
1.4
—
—
—
0
0
34
203
1.71
2.22
2.4
1.7
—
—
—
0
0
5
9
5.59
2.21
1.4
3.6
—
—
—
0
0
7
19
3.71
2.15
2.0
3.9
202.86
220.11
u/l
—
7
19
6
14
4.32
2.15
1.0
1.1
—
—
—
0
0
12
49
2.48
2.11
2.0
2.4
—
—
—
0
0
276
2421
1.25
2.03
4.9
3.7
0.00
0.00
estimate
0.50
39
467
23
128
1.83
1.92
1.1
1.1
—
—
—
0
0
5
142
0.35
1.90
1.0
1.5
—
—
—
0
0
11
46
2.42
1.86
2.2
2.5
—
—
—
0
0
6
17
3.55
1.84
1.2
1.1
99.17
91.29
%
—
6
17
6
18
3.35
1.75
1.8
3.1
25.00
36.15
umol/l
—
6
13
273
2421
1.23
1.74
6.2
5.1
0.00
0.00
estimate
0.50
40
432
80
613
1.35
1.67
2.4
3.0
5.40
8.78
umol/l
2.33
67
544
275
2451
1.22
1.65
4.9
3.7
0.00
0.01
estimate
0.50
37
424
21
120
1.78
1.64
1.3
1.4
—
—
—
0
0
8
33
2.44
1.54
1.0
1.5
—
27.40
—
0
5
559
5384
1.34
1.53
13.0
10.5
26.97
26.48
u/l
0.28
545
5186
22
131
1.70
1.51
1.2
1.7
—
—
—
0
0
6
21
2.87
1.51
1.0
2.0
—
—
—
0
0
6
21
2.87
1.51
1.0
2.0
—
—
—
0
0
5
16
3.14
1.44
1.8
1.9
—
—
—
0
0
16
88
1.84
1.42
3.2
5.0
—
526.33
—
0
9
171
1472
1.22
1.42
3.7
3.2
1642.13
198.78
mg/l
1.16
115
944
485
4603
1.23
1.42
6.8
5.8
40.18
40.05
mmol/mol
0.09
456
4254
174
1505
1.22
1.38
3.2
3.3
925.10
1469.36
ng/l
1.97
148
1292
81
644
1.30
1.33
4.7
4.5
33.02
31.74
%
0.46
65
417
12
61
1.99
1.33
1.6
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
25
161
1.58
1.30
2.1
5.9
0.40
0.31
u/ml
0.49
17
86
8
34
2.37
1.29
1.5
1.3
—
—
—
0
0
8
34
2.37
1.29
1.5
1.3
—
—
—
0
0
152
1311
1.21
1.24
6.3
3.9
0.00
0.01
estimate
0.69
37
420
11
56
1.98
1.22
1.0
2.0
—
—
—
0
0
22
140
1.59
1.21
2.5
1.4
17.71
9.07
u/l
1.10
17
105
495
4733
1.21
1.21
18.4
13.2
83.61
80.30
ml/min/173m2
2.53
426
3901
508
4876
1.22
1.15
5.0
4.5
6.06
5.97
mmol/l
0.80
479
4420
7
30
2.35
1.12
1.9
1.7
—
—
—
0
0
15
88
1.72
1.12
1.2
1.6
—
—
—
0
0
35
252
1.41
1.11
1.1
1.0
—
—
—
0
0
7
31
2.27
1.10
1.6
1.2
—
—
—
0
0
7
31
2.27
1.10
1.6
1.2
—
—
—
0
0
19
120
1.60
1.09
1.7
2.1
130.50
129.25
g/l
0.07
14
84
5
21
2.39
1.09
2.0
1.1
6.20
7.20
mmol/l
—
5
21
7
32
2.20
1.08
1.1
1.3
—
—
—
0
0
9
46
1.97
1.04
1.0
1.7
—
—
—
0
0
9
46
1.97
1.04
1.0
1.7
—
—
—
0
0
9
46
1.97
1.04
1.0
1.7
—
—
—
0
0
5
22
2.28
1.03
1.0
1.5
—
—
—
0
0
5
22
2.28
1.03
1.0
2.0
—
—
—
0
0
5
22
2.28
1.03
1.2
1.1
8.60
33.58
u/l
—
5
22
5
22
2.28
1.03
1.2
1.1
44.00
115.55
u/l
—
5
22
176
1564
1.17
1.02
3.8
3.8
8.52
10.25
mg/mmol
0.29
113
987
12
68
1.78
1.01
1.3
1.6
—
—
—
0
0
91
1078
0.82
1.00
3.5
3.1
0.85
0.80
ug/l
0.19
70
718
17
107
1.61
1.00
5.9
8.5
1496.80
345.71
iu/ml
—
5
17
5
23
2.18
0.98
1.0
1.4
—
—
—
0
0
5
23
2.18
0.98
1.2
1.7
1.52
1.20
nmol/l
—
5
15
7
36
1.95
0.97
1.0
1.1
—
—
—
0
0
6
27
2.23
0.93
1.0
1.9
—
—
—
0
0
6
27
2.23
0.93
1.0
1.9
—
—
—
0
0
48
379
1.29
0.88
2.3
2.9
66.36
65.47
ml/min/173m2
0.05
25
159
15
96
1.58
0.85
2.1
3.3
3.31
4.45
e9/l
2.82
15
96
92
789
1.19
0.82
1.4
1.2
3.13
12.14
u/ml
2.93
37
293
14
89
1.59
0.81
1.0
1.9
—
—
—
0
0
14
89
1.59
0.81
1.0
1.9
—
—
—
0
0
14
89
1.59
0.81
2.1
1.6
—
—
—
0
0
0
24
0.00
0.79
0.0
5.2
—
37.00
—
0
6
205
1879
1.13
0.77
5.5
3.9
—
—
—
0
0
15
99
1.53
0.76
2.2
3.7
54.80
57.85
%
0.55
15
99
9
53
1.71
0.75
2.3
2.5
—
—
—
0
0
32
245
1.32
0.75
4.2
3.2
0.73
0.65
%
0.75
32
245
33
254
1.32
0.75
4.1
3.2
1.40
1.21
%
0.39
33
254
12
76
1.59
0.72
1.5
1.4
—
—
—
0
0
12
77
1.57
0.69
1.6
1.4
—
—
—
0
0
12
77
1.57
0.69
1.6
1.4
—
—
—
0
0
10
155
0.64
0.66
1.8
1.9
—
—
—
0
0
12
78
1.55
0.66
1.6
1.4
—
—
—
0
0
12
78
1.55
0.66
1.6
1.4
—
—
—
0
0
12
78
1.55
0.66
1.6
1.4
—
—
—
0
0
7
44
1.60
0.65
1.1
1.0
—
—
—
0
0
17
120
1.43
0.65
1.0
1.9
—
—
—
0
0
58
490
1.20
0.63
3.7
2.3
54.02
35.15
u/l
0.30
50
413
574
5640
1.20
0.62
30.2
21.2
261.21
246.83
e9/l
5.12
563
5493
16
113
1.43
0.61
1.3
1.5
—
—
—
0
0
8
51
1.58
0.60
1.0
1.1
—
—
—
0
0
17
122
1.40
0.60
1.0
1.8
—
—
—
0
0
0
21
0.00
0.60
0.0
3.2
—
—
—
0
0
0
21
0.00
0.60
0.0
3.2
—
—
—
0
0
574
5643
1.19
0.60
30.4
21.2
4.42
4.50
e12/l
3.18
562
5485
574
5646
1.19
0.57
30.6
21.4
133.14
135.40
g/l
2.93
566
5552
6
36
1.67
0.57
1.2
1.1
—
—
—
0
0
6
36
1.67
0.57
1.2
1.1
—
—
—
0
0
6
37
1.63
0.55
1.2
1.1
—
—
—
0
0
6
37
1.63
0.55
1.0
1.8
—
—
—
0
0
6
37
1.63
0.55
1.2
1.1
—
—
—
0
0
6
37
1.63
0.55
1.0
1.8
—
—
—
0
0
6
37
1.63
0.55
1.2
1.1
—
—
—
0
0
573
5638
1.18
0.55
30.2
21.4
39.56
40.10
%
1.31
541
5264
478
4896
0.90
0.50
4.7
4.4
1.42
1.45
mmol/l
0.95
455
4477
461
4729
0.91
0.49
4.3
3.9
1.41
1.28
mmol/l
2.45
437
4309
10
69
1.46
0.44
1.3
1.6
—
—
—
0
0
8
58
1.38
0.41
1.1
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
92.00
—
0
8
0
15
0.00
0.41
0.0
1.9
—
96.50
—
0
8
11
79
1.40
0.41
1.2
1.2
—
—
—
0
0
12
88
1.37
0.40
1.0
1.8
—
—
—
0
0
144
1344
1.09
0.40
2.8
2.8
4029.40
8374.84
umol/l
0.56
125
1178
484
4932
0.92
0.37
4.8
4.4
4.55
4.61
mmol/l
0.67
459
4539
9
70
1.29
0.36
1.0
1.0
—
—
—
0
0
6
44
1.37
0.34
1.0
1.3
—
—
—
0
0
6
45
1.34
0.34
1.0
1.3
—
—
—
0
0
23
192
1.21
0.32
2.5
1.4
45.78
23.00
iu/l
1.56
17
154
17
137
1.25
0.32
1.4
1.4
—
—
—
0
0
19
156
1.22
0.31
1.4
1.3
—
—
—
0
0
142
1499
0.93
0.29
4.3
4.5
21.34
21.21
%
0.03
69
728
8
63
1.27
0.28
1.0
1.8
—
—
—
0
0
8
63
1.27
0.28
1.0
1.8
—
—
—
0
0
304
3126
0.95
0.27
3.1
2.9
—
—
—
0
0
59
644
0.91
0.27
1.3
1.4
—
—
—
0
0
8
66
1.21
0.27
1.6
1.3
7.29
7.69
mmol/l
—
8
55
5
74
0.67
0.26
1.6
2.8
105.80
105.45
mmol/l
—
5
74
10
125
0.80
0.23
2.1
1.4
—
—
—
0
0
5
40
1.25
0.22
4.0
2.5
532.00
595.74
ml
—
5
23
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
22.49
—
0
11
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
6
49
1.23
0.20
1.0
1.9
—
—
—
0
0
15
127
1.19
0.19
1.5
1.6
29484.50
9374.97
e6/l
—
10
97
47
509
0.92
0.19
3.2
3.2
—
—
—
0
0
7
60
1.17
0.18
1.4
1.7
—
—
—
0
0
7
62
1.13
0.17
3.9
3.0
5.03
3.78
nmol/l
—
7
62
17
148
1.15
0.17
1.4
1.6
41.71
40.90
nmol/l
0.06
17
140
8
71
1.13
0.16
1.1
1.2
—
—
—
0
0
498
5026
0.96
0.15
5.3
4.9
2.68
2.73
mmol/l
0.47
467
4595
9
80
1.13
0.15
1.1
1.1
—
—
—
0
0
191
1869
1.03
0.11
5.3
5.1
2.66
2.71
ug/l
0.04
173
1654
82
850
0.96
0.11
1.6
1.5
—
—
—
0
0
8
75
1.07
0.07
1.0
1.6
—
—
—
0
0
8
76
1.05
0.07
1.3
1.1
—
—
—
0
0
132
1346
0.98
0.07
1.7
1.7
1.52
1.37
mmol/l
0.73
118
1124
41
428
0.96
0.07
2.1
2.0
—
—
—
0
0
8
92
0.87
0.07
1.4
1.2
8.45
36.49
u/l
—
8
79
13
120
1.09
0.05
1.7
1.4
—
—
—
0
0
15
141
1.07
0.03
1.9
1.6
—
—
—
0
0
10
93
1.08
0.02
1.2
1.1
2.50
1.23
u/ml
—
5
54
11
117
0.94
0.01
1.3
1.4
—
—
—
0
0
13
123
1.06
0.01
1.2
1.3
—
—
—
0
0
14
133
1.05
0.01
1.2
1.4
—
—
—
0
0
32
315
1.02
0.00
1.2
1.2
222.91
145.52
iu/ml
0.29
11
112
48
477
1.01
0.00
2.1
2.1
—
—
—
0
0
56
557
1.01
0.00
2.6
4.4
15.04
34.11
ug/l
0.52
39
469
23
229
1.00
0.00
2.4
1.8
—
—
—
0
0
6
59
1.02
0.00
3.3
3.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
8
88
0.91
-0.00
1.1
1.1
1.84
1.48
g/l
—
8
82
0
9
0.00
-0.00
0.0
1.0
—
115.78
—
0
9
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
18
180
1.00
-0.00
1.9
1.8
—
—
—
0
0
5
57
0.88
-0.00
1.2
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
8.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
7.06
—
0
5
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.7
—
66.19
—
0
7
5
50
1.00
-0.00
1.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: R18_OTHER_LACK_COORD – Other lack of coordination
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).